From the TRIPS Agreement to the Public Health Declaration---On the New Development of the International Compulsory Patent Licensing System and Its Impact by 周纯
学校编码：10384                            分类号        密级         




硕 士 学 位 论 文 
 
从 TRIPS 协定到《公共健康宣言》 
——论国际专利强制许可制度的新发展及其对公共健康的影响 
From the TRIPS Agreement to the Public 
Health Declaration 
——On the New Development of the International Compulsory  
Patent Licensing System and Its Impact on the Public Health 
 
周  纯  
 
指导教师姓名： 古祖雪   教授 
专 业 名 称： 法 律 硕 士 
论文提交日期： 2005 年 11 月 
论文答辩时间： 2 0 0 5 年    月 
学位授予日期： 2 0 0 5 年    月 
 
答辩委员会主席             
评    阅    人             
 






















































































                        声明人（签名）： 
























  1、保密（ ），在   年解密后适用本授权书。 




作者签名：      日期：  年 月 日 























从 TRIPS 协定到《公共健康宣言》 
 




的《与贸易有关的知识产权协议》（以下简称 TRIPS），特别是其中第 31 条却对
这种限制规定了更严格的限制，从而弱化了对社会公众利益的保护。TRIPS 实施
后，国际社会发现 TRIPS 第 31 条规定与公共健康之间存在着内在冲突，是引发
发展中国家，特别是 不发达国家公共健康危机的重要因素。在国际社会压力下，
TRIPS 理事会就公共健康问题进行谈判并发表《TRIPS 协定与公共健康多哈宣
言》和《实施 TRIPS 协定与公共健康多哈宣言第六段决议》，对 TRIPS 第 31 条
作了扩大解释。 
本文通过对上述文件的形成及主要内容进行分别介绍和比较评析，指出，
TRIPS 第 31 条在国际专利强制许可制度上所增加的众多限制，实质上是扩大了
专利权保护，损害了发展中成员方的公共健康利益。《TRIPS 协定与公共健康多
哈宣言》和《实施 TRIPS 协定与公共健康多哈宣言第六段决议》的出台是对 TRIPS






















Compulsory patent licensing is an important part of the patent system, reflecting 
the restrictions on patent rights and the protection of the interests of the public as 
users. However, the WTO’s Agreement on Trade-Related Aspects of Intellectual 
Property Rights, Including Trade in Counterfeit Goods(TRIPS), which was made with 
the strong insistence of developed countries such as the United States, in particular its 
Article 31, provides stricter limitations on this restrictive regulation, thereby 
weakening the protection of public interests. Since the implementation of the TRIPS 
Agreement, the international community has found that there exists an intrinsic 
conflict between the provisions of Article 31 of the TRIPS Agreement and public 
health and constitutes a major factor that triggers the crisis of public health of 
developing countries, especially the least developed countries. Under the pressure of 
the international community, the TRIPS Council has initiated negotiations regarding 
the issue of public health and released the Doha Declaration on the TRIPS Agreement 
and Public Health and the Decision of the Implementation of Paragraph 6 of the Doha 
Declaration on the TRIPS Agreement and Public Health, which provides an expanded 
interpretation of Article 31 of the TRIPS Agreement.  
This paper introduces and conducts a comparative analysis of the formation of 
the above documents and their major contents, pointing out that the multitude of 
restrictions imposed by Articles 31 of the TRIPS Agreement has, in essence, expanded 
the protection of patent rights and undermined the interest of the public health of 
developing member states. The release of the Doha Declaration and the Resolution is 
breakthrough of Article 31 of the TRIPS Agreement, reflecting the embrace of 
humanistic values and ideals. In particular, the Resolution provides an interest 
coordinating mechanism under the “differentiated protection” model for member 
states with different economic development levels, making it a major victory for 
developing member states in the WTO system. The two have obvious positive 
significance, yet there are limitations; as such, developing member states still need to 
seek measures other than the compulsory patent licensing in order to solve the public 
health issue of their country.  
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1994 年 4 月，《与贸易有关的知识产权协议》（以下简称 TRIPS）签订后，
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会有条件地一致通过并发表《实施 TRIPS 协定与公共健康多哈宣言第六段决议》
（以下简称《决议》），就上述问题提出了临时性的解决方案。 
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第一章  专利强制许可制度概述 
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② Edith Tilton Penrose.The Economics of the International Patent System[M]. Johns Hopkins Press.1951. 转引
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国际法上，有关专利强制许可制度 早规定于 1883 年的《保护工业产权巴
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